Resources

AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.

To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database

Results

showing 1-10 of 785

Tell Congress to Reject Cuts and #SaveHIVFunding

Join us in telling Congress to reject cuts and #SaveHIVFunding by sending letters to your Congressional representatives.

February 2024


PrEP Initiations by Country Worldwide

AVAC tracks global PrEP use by conducting quarterly surveys of ongoing oral PrEP demonstration and implementation projects, and collecting data from manufacturers and government agencies. This graphic shows data on PrEP initiations around the globe....

Prevention Option:

February 2024


HIV Vaccine and Antibody Efficacy Trials to Date

This infographic provides a comprehensive overview of HIV vaccine and antibody efficacy trials. Over 20 years and 12 trials, only two positive signals have been observed.

February 2024


Decolonizing Global Health in 2024 and Beyond

In the year ahead, staking out a course that will advance the HIV response and global health equity faces serious headwinds.

February 2024


Coalition to Accelerate Access to Long-Acting PrEP

The Coalition to Accelerate Access to Long-Acting PrEP brings together leading donors, agencies, and advocates aimed at a practical goal: jointly develop strategies and take coordinated action to identify and overcome access challenges to just-approved and future PrEP options. AVAC serves as the Secretariat.

Prevention Option:

February 2024


Coalition to Accelerate Access to Long-Acting PrEP

A new initiative bringing together leading donors, agencies and advocates to ensure an accelerated and equitable approach to making longer-acting PrEP options accessible as quickly and as equitably as possible.

Prevention Option:

February 2024


What is PrEP Access Right Now and What’s Next in 2024?

AVAC is thrilled to see the launch of injectable cabotegravir for PrEP (injectable CAB) in Zambia—the first program outside of the US to do so. And the Desmond Tutu Health Foundation in South Africa recently announced “the first jab” of injectable CAB administered in its FASTPrEP study.

Prevention Option:

February 2024


What You Should Know About the FAPP, GAPP and PEPFAR Reauthorization

Engaging the US government is vital to advocacy for HIV prevention, as one of the world’s largest contributors to implementation and research and development. Two coalitions, founded by advocates, make it their central mission to inform and influence the US federal government to advance funding and policies to end the HIV epidemic.

February 2024


HIV Cure and the Environment

AVAC and REACH for the Cure hosted a webinar to discuss how the environment may impact HIV cure strategies.

Prevention Option:

February 2024


Advocacy Navigator Call for Mentor Applications

The Advocacy Navigator program is open to any AVAC Alumni interested in serving as a mentor to emerging HIV prevention advocates currently residing in Southern or Eastern Africa. This is a six month program in HIV prevention advocacy. The mentor...

February 2024


showing 1-10 of 785